Skip to main content

Advertisement

Table 1 Clinicopathologic characteristics of patients with localized prostate cancer who underwent moderately hypofractionated, intensity-modulated radiotherapy

From: Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer

Characteristic Number of patients [cases (%)]
Gleason score
 ≤ 6 274 (46.0)
 7 240 (40.3)
 ≥ 8 82 (13.8)
T stage
 T1–T2b 577 (96.8)
 T2c 5 (0.8)
 ≥ T3 14 (2.3)
Pretreatment PSA level (mg/dL)
 ≤ 10 467 (78.4)
 > 10 and ≤ 20 98 (16.4)
 > 20 31 (5.2)
D’Amico category
 Low risk 226 (37.9)
 Intermediate risk 264 (44.3)
 High risk 106 (17.8)
ADT in risk groups
 Low-risk 48 (21.2)
 Intermediate-risk 208 (78.8)
 High-risk 105 (99.1)
  1. PSA prostate-specific antigen, ADT androgen deprivation therapy